FDA approves Novavax COVID vaccine with new conditions

The U.S. Food and Drug Administration approved Novavax’s COVID-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

See the original article at: Honolulu Star-Advertiser